Dr. Clinton Haley, M.D.
What this data tells you about Dr. Haley
Dr. Clinton Haley is an infectious disease in Dallas, TX, with 17 years in practice. Based on federal Medicare data, Dr. Haley performed 34,453 Medicare services across 1,741 unique beneficiaries.
Between the years covered by Open Payments, Dr. Haley received a total of $15,495 from 38 pharmaceutical and/or device companies across 834 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Haley is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 30,841 | $18 | $50 |
| Hospital follow-up visit, moderate complexity | 1,175 | $62 | $202 |
| Drug injection, under skin or into muscle | 708 | $10 | $59 |
| Office visit, established patient (30-39 min) | 417 | $78 | $279 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 309 | $49 | $394 |
| Administration of chemotherapy into vein, 1 hour or less | 197 | $99 | $444 |
| Injection, zoledronic acid, 1 mg | 190 | $6 | $41 |
| Initial hospital admission, high complexity | 177 | $137 | $546 |
| Hospital follow-up visit, high complexity | 137 | $93 | $289 |
| Administration of chemotherapy into vein, each additional hour | 96 | $21 | $102 |
| Office visit, established patient (20-29 min) | 70 | $43 | $185 |
| Initial hospital admission, moderate complexity | 54 | $103 | $372 |
| New patient office visit (45-59 min) | 29 | $117 | $433 |
| Insertion of tube for infusion with imaging guidance and review by radiologist, patient 5 years or older | 21 | $313 | $1,225 |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 17 | $83 | $303 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 15 | $19 | $57 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Haley is a mixed practice specialist, with above-average Medicare volume (top 4% in TX), and high industry engagement (low-engagement, top 11%), with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Haley experienced with denosumab injection (prolia/xgeva)?
Does Dr. Haley receive payments from pharmaceutical companies?
How do Dr. Haley's costs compare to other infectious diseases in Dallas?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology